Physician profile
Jon Michael Cuba
NPI 1124126388
$1,286.20
in general payments reported to CMS, 2019-2025
10 companies · $161 in 2025
The $161 reported for 2025 was more than what 77% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.86 · 2022: $329 · 2023: $217 · 2024: $483 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $477.42 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $161.05 | 2025 | Flowtriever |
| Janssen Pharmaceuticals, INC | $152.61 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Janssen Scientific Affairs, LLC | $99.83 | 2024 | Xarelto |
| Gilead Sciences, INC. | $99.80 | 2023 | |
| Abiomed | $82.21 | 2022 | |
| Fisher & Paykel Healthcare INC | $36.66 | 2022-2023 | Fisher & Paykel Healthcare |
| Abbvie INC. | $28.28 | 2024 | |
| Btg International INC. | $23.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Cuba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.